The 2026 testosterone label debate: what actually changed?
What the requested US testosterone label revisions mean, how TRAVERSE informed them, and why diagnosis and product-specific instructions still matter.
Read articleFor informational and research purposes only.
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Find a topic you’re curious about and take a closer look.
What the requested US testosterone label revisions mean, how TRAVERSE informed them, and why diagnosis and product-specific instructions still matter.
Read articleSURMOUNT-5 directly compared tirzepatide and semaglutide for weight loss. Learn what the 72-week averages mean and which treatment questions remain unanswered.
Read articleSURMOUNT-OSA showed fewer breathing events with tirzepatide. Learn how AHI, oxygen burden, symptoms and PAP reassessment fit together.
Read articleSURMOUNT-4 clarifies what happens after initial tirzepatide weight loss—and why ongoing treatment and an individualized maintenance plan are separate questions.
Read articleWhat SUMMIT found about worsening heart failure and daily function, and why its findings apply to a specific group with obesity and HFpEF.
Read articleWhat the OASIS trials established about elinzanetant—and why symptom efficacy, sleep outcomes and current approval need separate interpretation.
Read articleThe evidence behind tirzepatide's oral-contraception precaution, its four-week windows and the separate issue of vomiting or diarrhea.
Read articleTB-500's uncertain recovery evidence does not soften its anti-doping status. Athletes need separate answers about health, eligibility, and product identity.
Read articleForzinity's Barth syndrome approval is meaningful, but it does not establish healthy-aging or lifespan benefits. Here is what the human and animal findings show.
Read articleWhy potassium-rich eating, salt substitutes and supplements need different decisions when kidney function or medicines affect potassium removal.
Read articleTwo 2026 trials bring new evidence on vitamin K2 and coronary calcification. Their imaging findings do not yet establish fewer heart attacks.
Read articleCharcoal can change drug exposure in the gut. That real pharmacology is a reason for caution, not evidence for an everyday whole-body cleanse.
Read article86–97 of 600 articles